PMC5644596_01
Overview of the clinical manifestation, monitoring and therapy from starting nivolumab administration (D0).. Abbreviation: MDR-Kp, multidrug-resistant Klebsiella pneumoniae.
tcrm-13-1375Fig1.jpg
PMC5644596_01_tcrm-13-1375Fig1.jpg
f1-tcrm-13-1375
Following treatment with tigecycline and meropenem for <2 weeks, the lesion in the lower lobe of the left lung was well controlled (Figures 1 and 2).
The case reached radiological regression, except right pleural metastasis, after applying methylprednisolone as the secondary fibrosis became complicated after nivolumab treatment (A). Along with neutropenia, occurrence of a new lesion in the lower lobe of the left lung suspected to be carcinoma metastasis was revealed by chest CT; right pleural metastasis was also enlarged (B). Following treatment with tigecycline and meropenem for <2 weeks, lesion in the lower lobe of the left lung was well controlled (C).
tcrm-13-1375Fig2.jpg
PMC5644596_01_tcrm-13-1375Fig2.jpg
f2-tcrm-13-1375
Following treatment with tigecycline and meropenem for <2 weeks, the lesion in the lower lobe of the left lung was well controlled (Figures 1 and 2).